Interestingly, researchers also detected other systemic tumors in patients with such neurological diseases who were positive for ARHGAP26 antibodies, suggesting that anti-ARHGAP26 antibodies may be a potential tumor predictor in such patients [38, 39]. This evidence concerns the gene ARHGAP26 and neoplasm.